Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system
暂无分享,去创建一个
A. Hoffmann | W. Baumgärtner | M. Stangel | F. Hansmann | S. Gingele | T. Skripuletz | V. Gudi | C. K. Prajeeth | G. Berner | L. S. Tejedor | N. Jungwirth | K. Jacobsen
[1] L. Rashed,et al. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination. , 2015, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[2] R. Gold,et al. Pivotal role of choline metabolites in remyelination. , 2015, Brain : a journal of neurology.
[3] H. Lassmann. Mechanisms of white matter damage in multiple sclerosis , 2014, Glia.
[4] Vikramjeet Singh,et al. Long‐term impact of neonatal inflammation on demyelination and remyelination in the central nervous system , 2014, Glia.
[5] D. Borjesson,et al. Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow. , 2014, Veterinary immunology and immunopathology.
[6] Tatsuhide Tanaka,et al. Mechanisms of remyelination: recent insight from experimental models , 2014, Biomolecular concepts.
[7] L. Fan,et al. Strategies for myelin regeneration: lessons learned from development , 2014, Neural regeneration research.
[8] M. Stangel,et al. Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned , 2014, Front. Cell. Neurosci..
[9] W. Baumgärtner,et al. Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia , 2014, Brain, Behavior, and Immunity.
[10] B. van Ryssen,et al. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man , 2013, The Veterinary quarterly.
[11] S. Noack,et al. Analysis of surface protein expression in human bone marrow stromal cells: new aspects of culture-induced changes, inter-donor differences and intracellular expression. , 2013, Stem cells and development.
[12] M. Moltó,et al. Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model , 2013, Cell Death and Disease.
[13] A. Hoffmann,et al. Effects of Murine and Human Bone Marrow-Derived Mesenchymal Stem Cells on Cuprizone Induced Demyelination , 2013, PloS one.
[14] A. Hedayatpour,et al. Promotion of Remyelination by Adipose Mesenchymal Stem Cell Transplantation in A Cuprizone Model of Multiple Sclerosis , 2013, Cell journal.
[15] Vikramjeet Singh,et al. Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes , 2013, Neurotoxicity Research.
[16] R. Spang,et al. T cells become licensed in the lung to enter the central nervous system , 2012, Nature.
[17] T. Vigo,et al. The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms , 2012, Stem Cell Research & Therapy.
[18] Martin Stangel,et al. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. , 2011, Histology and histopathology.
[19] C. Trebst,et al. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system , 2011, Brain, Behavior, and Immunity.
[20] M. Stangel,et al. Spatial and Temporal Profiles of Growth Factor Expression during CNS Demyelination Reveal the Dynamics of Repair Priming , 2011, PloS one.
[21] M. Yen,et al. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells , 2011, Journal of Biomedical Science.
[22] Antonio Uccelli,et al. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? , 2010, Current opinion in immunology.
[23] M. Weller,et al. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). , 2010, Stem cells and development.
[24] Sjef Copray,et al. The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.
[25] Martin Stangel,et al. Regional differences between grey and white matter in cuprizone induced demyelination , 2009, Brain Research.
[26] Philippe M. Campeau,et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 , 2009, The Journal of Immunology.
[27] J. Joh,et al. Isolation and characterization of mouse mesenchymal stem cells. , 2008, Transplantation proceedings.
[28] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[29] T. Ben-Hur,et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. , 2008, Archives of neurology.
[30] K. Myhr,et al. The cuprizone model for demyelination , 2008, Acta neurologica Scandinavica. Supplementum.
[31] P. Martiat,et al. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells , 2008, BMC Genomics.
[32] Martin Stangel,et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. , 2008, The American journal of pathology.
[33] K Haastert,et al. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination , 2007, Neuropathology and applied neurobiology.
[34] G. Mancardi,et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.
[35] M. Chopp,et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice , 2005, Experimental Neurology.
[36] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[37] A. Caplan,et al. The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.
[38] P. Morell,et al. The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.
[39] W. Baumgärtner,et al. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.
[40] C. Krettek,et al. Analysis of Surface Protein Expression in Human Bone Marrow Stromal Cells : New Aspects of Culture-Induced Changes , Inter-Donor Differences and Intracellular Expression , 2013 .
[41] C. Beyer,et al. Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum , 2012, Journal of Molecular Neuroscience.
[42] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.